Abstract
Radioembolization represents an effective tool for the treatment of primary and secondary liver tumors. Adequate use of this therapy requires knowledge and a multidisciplinary effort in order to obtain optimal results and avoid therapy-specific complications. A great deal of research has been undertaken in order to understand the angiographic, technical, and safety aspects concerning liver radioembolization. The most common complications of radioembolization include non-target radiation (pancreatitis, GI ulcers, cholecystitis), radiation pneumonitis, radiation-induced liver disease (radiation hepatitis), and biliary complications.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Ashizawa K, Matsunaga N, Aso N et al (1991) Bile lake: a complication of transcatheter hepatic arterial infusion and embolization therapy. Nipon Iagaku Hoshasen Gakkai Zasshi 51:121–126
Carretero C, Munoz-Navas M, Betes M et al (2007) Gastroduodenal injury after radioembolization of hepatic tumors. Am J Gastroenterol 102:1–5
Covey AM, Brody LA, Maluccio MA, Getradjdman GJ, Brown KT (2002) Variant hepatic arterial anatomy revisited: digital substraction angiography performed in 600 patients. Radiology 224:542–547
De Luis E, Bilbao JI, Garcia-Jalon de Ciercoles JA et al (2008) In vivo evaluation of a new embolic spherical particle “Hepasphere” in a kidney animal model. Cardiovasc Intervent Radiol 31(2):367–376
Kabayashi S, Nakamura Y, Terada T et al (1993) Postmortem survey of bile duct necrosis and biloma in hepatocellular carcinoma alter transcatheter arterial chemoembolization therapy: relevant to microvascular damages of peribiliary capillary plexus. Am J Gastroenterol 88:1410–1415
Kim HK, Cheng YH, Song BC et al (2001) Ischemic bile duct injury as a serious complication after transarterial chemoembolization in patients with hepatocellular carcinoma. J Clin Gastroenterol 32:423–427
Kim HC, Cheng JW, Lee W, Jae HJ, Park JH (2005) Recognizing extrahepatic collateral vessels that supply hepatocellular carcinoma to avid complications of transcatheter arterial chemoembolization. Radiographics 25:S25–S39
Lau WY, Ho S, Leung TW et al (1998) Selective internal radiation therapy for nonresectable hepatocellular carcinoma with intraarterial infusion of 90yttrium microspheres. Int J Radiat Oncol Biol Phys 40:583–592
Leung WT, Lau WY, Ho SK et al (1994) Measuring lung shunting in hepatocellular carcinoma with intrahepatic-arterial technetium-99 m macroaggregated albumin. J Nucl Med 35:70–73
Leung TW, Lau WY, Ho SK et al (1995) Radiation pneumonitis after selective internal radiation treatment with intraarterial 90yttrium-microspheres for inoperable hepatic tumors. Int J Radiat Oncol Biol Phys 33:919–924
Lewandosky RJ, Sato KT, Atassi B et al (2007) Radioembolization with 90Y microspheres: angiographic and technical considerations. Cadiovasc Intervent Radiol 30:571–592
Liu DM, Salem R, Bui JT et al (2005) Angiographic considerations in patients undergoing liver-directed therapy. J Vasc Interv Radiol 16:911–935
Makuchi M, Sukigara M, Mori T et al (1985) Bile duct necrosis: complication of transcatheter hepatic arterial embolization. Radiology 156:331–334
Mantravadi RV, Spigos DG, Tan WS et al (1982) Intraarterial yttrium 90 in the treatment of hepatic malignancy. Radiology 142:783–786
Nakamura H, Kondoh H (1986) Emphysematous cholecystitis: complications of hepatic arterial embolization. Cardiovasc Intervent Radiol 9:152–153
Northover JMA, Terblanche J (1979) A new look a the arterial supply of the bile duct in man and its surgical implications. Br J Surg 66:379–384
Park WK, Chang JC, Lee HZ, Kim HJ, Choi JH, Gu MJ (2002) A case of resection of biloma with hepatocellular carcinoma after embolization. TaehanKan Hakhoe Chi 8:331–335
Sakamoto I, Iwanaga S, Nagaoki K et al (2003) Intrahepatic biloma formation (bile duct necrosis) after transcatheter arterial chemoembolization. AJR Am J Roentgenol 181:79–87
Salem R, Thurston KG (2006) Radioembolization with 90Yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 1: technical and methodologic considerations. J Vasc Interv Radiol 17:1251–1278
Salem R, Lewandosky RJ, Atassi B et al (2005) Treatment of unresectable hepatocellular carcinoma with intrahepatic yttrium 90 microspheres: factors associated with liver toxicities. J Vasc Interv Radiol 16:1627–1639
Szyszko T, Al-Nahhas A, Tait P et al (2007) Management and prevention of adverse effects related to treatment of liver tumours with 90Y microspheres. Nucl Med Commun 28:21–24
Wollner IS, Knutsen CA, Ullrich KA et al (1987) Effects of hepatic arterial yttrium-90 microsphere administration alone and combined with regional bromodeoxyuridine infusion in dogs. Cancer Res 47:3285–3290
Yip D, Allen R, Ashton C et al (2004) Radiation-induced ulceration of the stomach secondary to hepatic embolization with radioactive yttrium microspheres in the treatment of metastatic colon cancer. J Gastroenterol Hepatol 19:347–349
Yu JS, Kim KW, Jeong MG et al (2002) Predisposing factors of bile duct injury after transcatheter arterial chemoembolization for hepatic malignancy. Cardiovasc Intervent Radiol 25:270–274
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Hoffmann, R., Diaz-Dorronsoro, L., Bilbao, J.I. (2013). Complications and Side Effects. In: Bilbao, J., Reiser, M. (eds) Liver Radioembolization with 90Y Microspheres. Medical Radiology(). Springer, Berlin, Heidelberg. https://doi.org/10.1007/174_2013_815
Download citation
DOI: https://doi.org/10.1007/174_2013_815
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-36472-3
Online ISBN: 978-3-642-36473-0
eBook Packages: MedicineMedicine (R0)